Riskpilot← Back to searchSign inGet full accessVITALIS APOTEK AS
ASActiveOrg 923623574Rosenkrantz' Gate 15, 0160 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20195 employees
Revenue 2024
NOK 10,1M
+91% vs 2023
EBITDA margin
-8.7%
+14% vs 2023
Equity ratio
-1.0%
Financial strength
Net profit 2024
NOK -944K
-11% vs 2023
| Revenue | NOK 10,1M | +91% |
| EBITDA | NOK -881K | +14% |
| Net profit | NOK -944K | -11% |
| Total assets | NOK 3,9M | +14% |
| Equity | NOK -37K | +80% |
| Employees | 5 | — |
Legal name
VITALIS APOTEK AS
Org number
923623574
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
29. oktober 2019
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og relaterte produkter, aktuelle konsulent og rådgivningstjenester.
Address
Rosenkrantz' Gate 15, 0160 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 5 281 | 10 107 |
| Staff expenses | −0 | −0 | −0 | −2 213 | −3 072 |
| EBITDA | −25 | 0 | −90 | −1 022 | −881 |
| Depreciation & amort. | −0 | −0 | −1 | −51 | −51 |
| EBIT | −25 | 0 | −91 | −1 073 | −932 |
| Net financials | 0 | −3 | 0 | 0 | −12 |
| Profit before tax | −25 | −3 | −91 | −1 072 | −944 |
| Tax | −0 | −0 | −0 | −222 | −0 |
| Net profit | −25 | −3 | −91 | −850 | −944 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 | 0 | 84 | 3 393 | 3 858 |
| Equity | −37 | −40 | −128 | −190 | −37 |
| Long-term debt | 40 | 40 | 189 | 1 855 | 2 426 |
| Short-term debt | 0 | 0 | 22 | 1 728 | 1 469 |
| Total debt | 40 | 40 | 212 | 3 583 | 3 895 |
EBITDA margin
-8.7%
This company
15.8%
Market median
-155% vs market
20202024
Equity ratio
-1.0%
This company
38.2%
Market median
-103% vs market
20202024
Return on equity
-94368800.0%
This company
18.4%
Market median
-512874013% vs market
20202024
Net profit margin
-9.3%
This company
8.1%
Market median
-215% vs market
20202024
Asset turnover
2.62×
This company
1.12×
Market median
+134% vs market
20202024
Debt / equity
105.17×
This company
0.62×
Market median
-16863% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
KX Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
KX Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norsund Gruppen As
VITALIS APOTEK AS Board members of VITALIS APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katrina Xue Lønmo | Chief Executive Officer | 0 companies |
| Katrina Xue-Lønmo | Chief Executive Officer | 0 companies |
| Yunlin Zhan | Chairman | 0 companies |